- For patients
- For specialists
Data on coexisting Graves’ disease (GD), hypoparathyroidism, and autoimmune hemolytic anemia are limited. Here we report an uncommon case of autoimmune disorder causing Graves’ disease with autoimmune hemolytic anemia and along with mineralization of basal ganglia.
The article is devoted to the study of treatment results of patients with diffuse toxic goitre. A research aim is an estimation of therapeutic efficiency, safety and tolerability of carbimazole (Еspa-Carb) in comparison with thiamazole (Mercazolil-Zdorovie) in patients with hyperthyroidism.
There are three major methods that are currently used for treatment of hyperthyroidism: medication (antithyroid drugs), radioiodine therapy and surgical intervention (thyroidectomy).
Thionamides are considered the main drugs for treatment of diffuse toxic goitre (DTG). Thiamazole, carbimazole and propylthiouracil are the most frequently used thyreostatic drugs.